Insider Stock Trading History of Hemmi Gregory


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hemmi Gregory since year 2005. The trader's CIK number is 1507649. At the time of this reporting, Hemmi Gregory is the VP Chemical Operations of Pharmacyclics Inc . (stock ticker symbol PCYC). See this page for all insider trading activities at Pharmacyclics Inc .


Stock purchases, sales, and option exercises reported by insider Hemmi Gregory since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-03-05 PCYC Pharmacyclics Inc Option Ex 15,000 .86 12,900
2014-03-05 PCYC Pharmacyclics Inc Sale 15,000 140.00 2,100,030
2013-12-30 PCYC Pharmacyclics Inc Option Ex 13,000 .75 9,750
2013-12-18 PCYC Pharmacyclics Inc Option Ex 10,000 .86 8,600
2013-12-17 PCYC Pharmacyclics Inc Sale 10,000 102.00 1,020,000
2013-12-18 PCYC Pharmacyclics Inc Sale 10,000 99.04 990,380
2013-12-17 PCYC Pharmacyclics Inc Option Ex 10,000 .86 8,600
2013-05-31 PCYC Pharmacyclics Inc Option Ex 50,000 1.81 90,500
2013-05-31 PCYC Pharmacyclics Inc Sale 50,000 91.96 4,598,100
2013-01-11 PCYC Pharmacyclics Inc Option Ex 5,000 4.89 24,465
2013-01-11 PCYC Pharmacyclics Inc Sale 5,000 67.11 335,550
2012-12-26 PCYC Pharmacyclics Inc Option Ex 100 4.47 447
2012-12-27 PCYC Pharmacyclics Inc Option Ex 12,900 7.84 101,136
2012-12-26 PCYC Pharmacyclics Inc Sale 100 59.00 5,900
2012-12-27 PCYC Pharmacyclics Inc Sale 12,900 59.50 767,550
2012-05-08 PCYC Pharmacyclics Inc Option Ex 1,875 4.25 7,968
2011-12-30 PCYC Pharmacyclics Inc Option Ex 18,125 6.34 114,966
2011-12-30 PCYC Pharmacyclics Inc Sale 18,125 14.91 270,243
2011-07-13 PCYC Pharmacyclics Inc Option Ex 6,000 .75 4,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hemmi Gregory (VP Chemical Operations of Pharmacyclics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.